Involved Investigator Sites:
No involved investigator sites defined.
amphiregulin, CA15-3, CD14, epidermal growth factor (EGF), EGF receptor, E-selectin, basic fibroblast growth factor, heparin-binding EGF, Her2, hepatocyte growth factor, intracellular adhesion molecule, insulin-like growth factor 1, interleukins 1 and 18, matrix metalloproteases 1, 2 and 9, platelet-derived growth factor, prostate-selective antigen, RANTES, transforming growth factor , tissue necrosis factor , urokinase plasminogen activator, vascular endothelial growth factor
Field(s) of Research:
Collaborative Group Text:
Breast and Gynecologic Cancers Research
To evaluate the effects of receptor status on circulating biomarker levels.
To analyze plasma levels of 24 proteins in 60 samples from women with either benign breast disease, or Her+ or ER+ cancers.
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.